Ashley Cordova, Chief Executive Officer at NovoCure Ltd (NVCR), sold 22,839 shares at $19.92 ($452K) on 2025-02-27, disclosed to the SEC on 2025-03-03.
Seasonal sale ($452k) by Chief Executive Officer — this insider has traded NVCR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.92 | 9,345 | $186K | 41.2% |
| 2 | $19.92 | 9,345 | $186K | 41.2% |
| 3 | $20.55 | 1,808 | $37K | 8.2% |
| 4 | $18.28 | 2,341 | $43K | 9.5% |
| Total | $19.80 avg | 22,839 | $452K | 100% |
| Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |
| NVCR | SELL | 2023-08-04 | $35K | — | Filing → |